2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Nivolumab - Autoimmune Diseases, Non-small Cell Lung Cancer | Phase 1 | Terminated | Alliance Foundation Trials, LLC. | 7 | 2019-06-27 | 2023-02-15 |
| Ustekinumab for the Treatment of Giant Cell Arteritis Ustekinumab, Prednisone - Giant Cell Arteritis, Temporal Arteritis | Phase 1 / Phase 2 | Terminated | Massachusetts General Hospital | 13 | 2016-12-01 | 2020-06-12 |
Giant Cell Arteritis (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Carcinoma, Non-Small-Cell Lung (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Lupus Erythematosus, Systemic (1) · Multiple Sclerosis (1) · Polymyalgia Rheumatica (1) · Psoriasis (1)
Autoimmune Diseases of the Nervous System (2) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Vascular Diseases (2) · Vasculitis (2) · Vasculitis, Central Nervous System (2) · Arthritis (1)
Nivolumab (1) · Prednisone (1) · Ustekinumab (1)
Alliance Foundation Trials, LLC. (1) · Massachusetts General Hospital (1)
United States (2)